Leerink Partnrs Forecasts Increased Earnings for CVS Health

CVS Health Co. (NYSE:CVS) – Leerink Partnrs upped their Q2 2025 EPS estimates for CVS Health in a research note issued on Monday, November 18th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will post earnings per share of $1.71 for the quarter, up from their previous estimate of $1.64. The consensus estimate for CVS Health’s current full-year earnings is $5.48 per share. Leerink Partnrs also issued estimates for CVS Health’s Q3 2025 earnings at $1.81 EPS.

A number of other equities research analysts have also commented on CVS. Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $59.00 to $85.00 in a research note on Friday, October 4th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Evercore ISI increased their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $72.28.

CVS Health Trading Up 1.9 %

Shares of CVS stock opened at $56.83 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $71.52 billion, a P/E ratio of 14.42, a P/E/G ratio of 0.92 and a beta of 0.55. CVS Health has a 12-month low of $52.71 and a 12-month high of $83.25. The firm has a 50-day moving average price of $59.18 and a 200 day moving average price of $58.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year.

Institutional Trading of CVS Health

Large investors have recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Crewe Advisors LLC bought a new position in CVS Health in the 1st quarter valued at approximately $40,000. Legacy Investment Solutions LLC bought a new stake in CVS Health during the 3rd quarter worth $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health in the third quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.68%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.